annual operating expenses:
$1.80B+$53.19M(+3.05%)Summary
- As of today (July 1, 2025), BMRN annual total operating expenses is $1.80 billion, with the most recent change of +$53.19 million (+3.05%) on December 31, 2024.
- During the last 3 years, BMRN annual operating expenses has risen by +$349.37 million (+24.09%).
- BMRN annual operating expenses is now at all-time high.
Performance
BMRN Operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly operating expenses:
$369.68M-$80.13M(-17.81%)Summary
- As of today (July 1, 2025), BMRN quarterly total operating expenses is $369.68 million, with the most recent change of -$80.13 million (-17.81%) on March 31, 2025.
- Over the past year, BMRN quarterly operating expenses has dropped by -$75.51 million (-16.96%).
- BMRN quarterly operating expenses is now -23.14% below its all-time high of $480.98 million, reached on December 31, 2023.
Performance
BMRN quarterly operating expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Operating expenses Formula
Operating Expenses = Selling, General & Administrative (SG&A) Expenses + Research & Development (R&D) Expenses + Depreciation & Amortization + Other Operating Expenses
BMRN Operating expenses Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +3.0% | -17.0% |
| 3 y3 years | +24.1% | -0.4% |
| 5 y5 years | +24.1% | +7.1% |
BMRN Operating expenses Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +24.1% | -23.1% | at low |
| 5 y | 5-year | at high | +26.0% | -23.1% | +9.2% |
| alltime | all time | at high | >+9999.0% | -23.1% | +8920.9% |
BMRN Operating expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2025 | - | $369.68M(-17.8%) |
| Dec 2024 | $1.80B(+3.0%) | $449.80M(+1.4%) |
| Sep 2024 | - | $443.41M(-3.8%) |
| Jun 2024 | - | $461.12M(+3.6%) |
| Mar 2024 | - | $445.19M(-7.4%) |
| Dec 2023 | $1.75B(+11.5%) | $480.98M(+26.7%) |
| Sep 2023 | - | $379.60M(-4.9%) |
| Jun 2023 | - | $399.09M(+0.1%) |
| Mar 2023 | - | $398.54M(-1.2%) |
| Dec 2022 | $1.57B(+8.0%) | $403.35M(+3.3%) |
| Sep 2022 | - | $390.53M(+5.4%) |
| Jun 2022 | - | $370.62M(-0.1%) |
| Mar 2022 | - | $371.07M(-5.9%) |
| Dec 2021 | $1.45B(+1.5%) | $394.29M(+10.6%) |
| Sep 2021 | - | $356.57M(-1.2%) |
| Jun 2021 | - | $360.81M(+6.6%) |
| Mar 2021 | - | $338.43M(-8.0%) |
| Dec 2020 | $1.43B(-1.5%) | $367.77M(+7.5%) |
| Sep 2020 | - | $342.05M(-8.2%) |
| Jun 2020 | - | $372.45M(+7.9%) |
| Mar 2020 | - | $345.26M(-3.3%) |
| Dec 2019 | $1.45B(+8.9%) | $357.07M(-0.9%) |
| Sep 2019 | - | $360.14M(-1.8%) |
| Jun 2019 | - | $366.63M(+0.3%) |
| Mar 2019 | - | $365.51M(+11.5%) |
| Dec 2018 | $1.33B(+9.9%) | $327.90M(-0.2%) |
| Sep 2018 | - | $328.55M(-3.1%) |
| Jun 2018 | - | $339.09M(+1.1%) |
| Mar 2018 | - | $335.49M(-3.9%) |
| Dec 2017 | $1.21B(+9.0%) | $349.26M(+21.1%) |
| Sep 2017 | - | $288.39M(-3.9%) |
| Jun 2017 | - | $299.95M(+9.5%) |
| Mar 2017 | - | $273.95M(-15.9%) |
| Dec 2016 | $1.11B(+9.0%) | $325.56M(+12.6%) |
| Sep 2016 | - | $289.24M(+30.2%) |
| Jun 2016 | - | $222.20M(-19.1%) |
| Mar 2016 | - | $274.54M(+10.1%) |
| Dec 2015 | $1.02B(+29.5%) | $249.37M(-2.5%) |
| Sep 2015 | - | $255.87M(-7.4%) |
| Jun 2015 | - | $276.36M(+16.2%) |
| Mar 2015 | - | $237.78M(-5.1%) |
| Dec 2014 | $787.41M(+28.0%) | $250.50M(+23.4%) |
| Sep 2014 | - | $202.93M(+13.1%) |
| Jun 2014 | - | $179.46M(+15.6%) |
| Mar 2014 | - | $155.19M(-14.2%) |
| Dec 2013 | $615.16M(+18.5%) | $180.97M(+13.4%) |
| Sep 2013 | - | $159.54M(+18.8%) |
| Jun 2013 | - | $134.29M(-4.3%) |
| Mar 2013 | - | $140.35M(-7.9%) |
| Dec 2012 | $519.11M(+32.7%) | $152.31M(+33.6%) |
| Sep 2012 | - | $113.99M(-13.2%) |
| Jun 2012 | - | $131.40M(+8.2%) |
| Mar 2012 | - | $121.41M(+12.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2011 | $391.23M(+28.1%) | $107.76M(+1.2%) |
| Sep 2011 | - | $106.50M(+13.4%) |
| Jun 2011 | - | $93.92M(+9.1%) |
| Mar 2011 | - | $86.05M(-5.1%) |
| Dec 2010 | $305.44M(+26.0%) | $90.70M(+16.7%) |
| Sep 2010 | - | $77.71M(+6.6%) |
| Jun 2010 | - | $72.93M(+12.6%) |
| Mar 2010 | - | $64.75M(+1.2%) |
| Dec 2009 | $242.32M(+18.7%) | $63.97M(+14.8%) |
| Sep 2009 | - | $55.70M(-5.0%) |
| Jun 2009 | - | $58.63M(-8.4%) |
| Mar 2009 | - | $64.02M(+15.2%) |
| Dec 2008 | $204.23M(+27.2%) | $55.55M(-1.2%) |
| Sep 2008 | - | $56.23M(+12.3%) |
| Jun 2008 | - | $50.05M(+18.1%) |
| Mar 2008 | - | $42.39M(-14.5%) |
| Dec 2007 | $160.51M(+60.3%) | $49.57M(+31.0%) |
| Sep 2007 | - | $37.85M(-0.2%) |
| Jun 2007 | - | $37.93M(+6.8%) |
| Mar 2007 | - | $35.51M(+18.5%) |
| Dec 2006 | $100.14M(+14.8%) | $29.97M(+13.4%) |
| Sep 2006 | - | $26.43M(+10.1%) |
| Jun 2006 | - | $24.00M(+21.5%) |
| Mar 2006 | - | $19.75M(-5.8%) |
| Dec 2005 | $87.25M(-46.3%) | $20.97M(+1.9%) |
| Sep 2005 | - | $20.59M(-6.1%) |
| Jun 2005 | - | $21.92M(-7.8%) |
| Mar 2005 | - | $23.77M(-74.8%) |
| Dec 2004 | $162.60M(+85.0%) | $94.15M(+251.7%) |
| Sep 2004 | - | $26.77M(+19.8%) |
| Jun 2004 | - | $22.35M(+15.6%) |
| Mar 2004 | - | $19.34M(-23.0%) |
| Dec 2003 | $87.90M(+30.0%) | $25.11M(+21.5%) |
| Sep 2003 | - | $20.67M(-4.2%) |
| Jun 2003 | - | $21.58M(+5.0%) |
| Mar 2003 | - | $20.54M(+32.8%) |
| Dec 2002 | $67.62M(+42.0%) | $15.47M(-16.9%) |
| Sep 2002 | - | $18.61M(+13.5%) |
| Jun 2002 | - | $16.40M(-4.4%) |
| Mar 2002 | - | $17.14M(+106.9%) |
| Dec 2001 | $47.63M(+4.9%) | $8.29M(-36.9%) |
| Sep 2001 | - | $13.14M(+0.7%) |
| Jun 2001 | - | $13.04M(+17.2%) |
| Mar 2001 | - | $11.13M(+32.1%) |
| Dec 2000 | $45.39M(+46.0%) | $8.43M(-34.0%) |
| Sep 2000 | - | $12.77M(+8.2%) |
| Jun 2000 | - | $11.80M(-4.8%) |
| Mar 2000 | - | $12.39M(+202.4%) |
| Dec 1999 | $31.10M(+110.1%) | $4.10M(-65.0%) |
| Sep 1999 | - | $11.70M(+33.0%) |
| Jun 1999 | - | $8.80M(+33.9%) |
| Mar 1999 | - | $6.57M |
| Dec 1998 | $14.80M | - |
FAQ
- What is BioMarin Pharmaceutical annual total operating expenses?
- What is the all time high annual operating expenses for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical annual operating expenses year-on-year change?
- What is BioMarin Pharmaceutical quarterly total operating expenses?
- What is the all time high quarterly operating expenses for BioMarin Pharmaceutical?
- What is BioMarin Pharmaceutical quarterly operating expenses year-on-year change?
What is BioMarin Pharmaceutical annual total operating expenses?
The current annual operating expenses of BMRN is $1.80B
What is the all time high annual operating expenses for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high annual total operating expenses is $1.80B
What is BioMarin Pharmaceutical annual operating expenses year-on-year change?
Over the past year, BMRN annual total operating expenses has changed by +$53.19M (+3.05%)
What is BioMarin Pharmaceutical quarterly total operating expenses?
The current quarterly operating expenses of BMRN is $369.68M
What is the all time high quarterly operating expenses for BioMarin Pharmaceutical?
BioMarin Pharmaceutical all-time high quarterly total operating expenses is $480.98M
What is BioMarin Pharmaceutical quarterly operating expenses year-on-year change?
Over the past year, BMRN quarterly total operating expenses has changed by -$75.51M (-16.96%)